About this trial
To develop a feedback-enabled magnetic device for management of blepharoptosis and evaluate its efficacy and safety, including the gain of palpebral fissure height, visual field obstruction, blurred vision, foreign body sensation over the cornea, burning or hot sensation over facial skin, and erythema or pruritus over the eyelid, by performing a human trial on patients with blepharoptosis.
Eligibility criteria
Qualifiers
Patients with ptosis; they are capable of understanding and complying with protocol requirements
Aged 18 years old or older
Disqualifiers
Upper eyelid scar, contracture, or fibrosis due to previous surgical intervention(s)
Patients with psychiatric (or mental) disorders; they are unable to cooperate or follow the study procedure
Children younger than 18 years of age
Trial design
Treatments tested in this trial
- Feedback-enabled magnetic device
Treatment groups
Sponsors and collaborators
E-DA Hospital
Lead sponsor
National Yang Ming Chiao Tung University
Collaborator
The Industrial Technology Research Institute
Collaborator
Shin Kong Wu Ho-Su Memorial Hospital
Collaborator
National Science and Technology Council, Taiwan
Collaborator